Rmr Wealth Builders Amgen Inc Transaction History

Rmr Wealth Builders

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$233.58 - $259.14 $54,657 - $60,638	-234 Closed	0 $0
Q1 2021 May 13, 2021	BUY	$221.91 - $258.6 $44,603 - $51,978	201 Added 609.09%	234 $58,000
Q4 2020 Feb 26, 2021	BUY	$216.38 - $257.67 $7,140 - $8,503	33 New	33 $8,000
Q3 2020 Nov 13, 2020	SELL	$234.65 - $260.95 $7,508 - $8,350	-32 Closed	0 $0
Q2 2020 Aug 19, 2020	SELL	$197.81 - $242.74 $6,527 - $8,010	-33 Reduced 50.77%	32 $8,000
Q4 2019 Mar 03, 2020	BUY	$189.21 - $243.2 $12,298 - $15,808	65 New	65 $16,000

3,075

417M

7.19M

6.28M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $169B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Rmr Wealth Builders, based on Form 13F filings with the SEC.

Stay updated on Rmr Wealth Builders with notifications on news.